Showing results (11-20 of 547) with videos related to

Sort By:
Pageof 55
European Urology|March 10, 2018
Twenty-year Risk of Prostate Cancer Death by Midlife Prostate-specific Antigen and a Panel of Four Kallikrein Markers in a Large Population-based Cohort of Healthy MenDaniel D Sjoberg, Andrew J Vickers, Melissa Assel, et al.
The Journal of Urology|September 6, 2016
Prostate Specific Antigen and Prostate Cancer in Chinese Men Undergoing Initial Prostate Biopsies Compared with Western CohortsRui Chen, Daniel D Sjoberg, Yiran Huang, et al.
Cancer|May 31, 2013
The Prostate Cancer Prevention Trial risk calculator and the relationship between prostate-specific antigen and biopsy outcomeAndrew J Vickers, Daniel D Sjoberg, Donna P Ankerst, et al.
The Journal of Urology|November 5, 2016
Detection of High Grade Prostate Cancer among PLCO Participants Using a Prespecified 4-Kallikrein Marker PanelEric H Kim, Gerald L Andriole, E David Crawford, et al.
The Journal of Urology|March 4, 2020
Prespecified 4-Kallikrein Marker Model at Age 50 or 60 for Early Detection of Lethal Prostate Cancer in a Large Population Based Cohort of Asymptomatic Men Followed for 20 YearsEmily A Vertosick, Christel Häggström, Daniel D Sjoberg, et al.
Urologic Oncology|October 17, 2017
Concordance between patient-reported and physician-reported sexual function after radical prostatectomyAlan E Thong, Bing Ying Poon, Justin K Lee, et al.
European Urology|August 22, 2015
Unexpected Long-term Improvements in Urinary and Erectile Function in a Large Cohort of Men with Self-reported Outcomes Following Radical ProstatectomyJustin K Lee, Melissa Assel, Alan E Thong, et al.
BJU International|August 30, 2014
Extended pelvic lymph node dissection in patients with prostate cancer previously treated with surgery for lower urinary tract symptomsNicola Fossati, Daniel D Sjoberg, Umberto Capitanio, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|November 6, 2023
Comparison of salvage radical prostatectomy vs. salvage ablation therapy for biopsy-proven radio-recurrent localized prostate cancerVictor McPherson, Shiva M Nair, Amy L Tin, et al.
European Urology|February 16, 2015
Improving the Specificity of Screening for Lethal Prostate Cancer Using Prostate-specific Antigen and a Panel of Kallikrein Markers: A Nested Case-Control StudyPär Stattin, Andrew J Vickers, Daniel D Sjoberg, et al.
Pageof 55